Molecular barriers to zoonotic transmission of prions

Emerging Infectious Diseases

Volumn 20, Issue 1, 2014, Pages 88-97

  Barria, Marcelo A ^a   Balachandran, Aru ^b   Morita, Masanori ^c   Kitamoto, Tetsuyuki ^d   Barron, Rona ^a   Manson, Jean ^a   Knight, Richard ^a   Ironside, James W ^a   Head, Mark W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b CANADIAN FOOD INSPECTION AGENCY   (Canada)

^c Japan Blood Products Organization   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL TISSUE; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; CHRONIC WASTING DISEASE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRION; VIRUS TRANSMISSION; WESTERN BLOTTING; ZOONOSIS;

BOVINE SPONGIFORM ENCEPHALOPATHY; BSE; CELL-FREE SYSTEM; CHRONIC WASTING DISEASE; CJD; CREUTZFELDT-JAKOB DISEASE; IN VITRO ASSAY; PRION DISEASE; PRIONS; PROTEIN MISFOLDING DISEASES; SCRAPIE; ZOONOSES;

ANIMALS; BRAIN; CATTLE; DISEASE SUSCEPTIBILITY; HUMANS; MICE; MICE, TRANSGENIC; PRION DISEASES; PRIONS; SHEEP; ZOONOSES;

EID: 84890940379     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2001.130858     Document Type: Article

References (40)

1. Benestad SL, Sarradin P, Thu B, Schoenheit J, Tanulis MA, Bratberg B. Cases of scrapie with unusual features in Norway and designation of a new type, Nor98. Vet Rec. 2003;153:202-8. http://dx.doi. org/10.1136/vr.153.7.202
2. Casalone C, Zanusso G, Acutis P, Ferrari S, Capucci L, Tagliavini F, et al. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A. 2004;101:3065-70. http:// dx.doi.org/10.1073/pnas.0305777101
3. Biacabe AG, Laplanche JL, Ryder S, Baron T. Distinct molecular phenotypes in bovine prion diseases. EMBO Rep. 2004;5:110-5. http://dx.doi.org/10.1038/sj.embor.7400054
4. Tranulis MA, Benestad SL, Baron T, Kretzschmar H. Atypical prion diseases in humans and animals. Top Curr Chem. 2011;305:23-50. http://dx.doi.org/10.1007/128_2011_161
5. Saunders SE, Bartelt-Hunt SL, Bartz JC. Occurrence, transmission, and zoonotic potential of chronic wasting disease. Emerg Infect Dis. 2012;18:369-76. http://dx.doi.org/10.3201/eid1803.110685
6. Le Dur A, Beringue V, Andreoletti A, Reine F, Lai TL, Baron T, et al. A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes. Proc Natl Acad Sci U S A. 2005;102:16031-6. http://dx.doi.org/10.1073/ pnas.0502296102
7. Jacobs JG, Langeveld JP, Biacabe AG, Acutis PL, Polak MP, Gavier-Widen D, et al. Molecular discrimination of atypical bovine spongiform encephalopathy strains from a geographical region spanning a wide area in Europe. J Clin Microbiol. 2007;45:1821-9. http://dx.doi.org/10.1128/JCM.00160-07
8. Castilla J, Gonzalez-Romero D, Saa P, Morales R, De Castro J, Soto C. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell. 2008;134:757-68. http:// dx.doi.org/10.1016/j.cell.2008.07.030
9. Orrú CD, Caughey B. Prion seeded conversion and amplification assays. Top Curr Chem. 2011;305:121-33. http://dx.doi. org/10.1007/128_2011_184
10. Jones M, Wight D, Barron R, Jeffrey M, Manson J, Prowse C, et al. Molecular model of prion transmission to humans. Emerg Infect Dis. 2009;15:2013-6. http://dx.doi.org/10.3201/eid1512.090194
11. Wilson R, Plinston C, Hunter N, Casalone C, Corona C, Tagliavini F, et al. Chronic wasting disease and atypical forms of bovine spongiform encephalopathy and scrapie are not transmissible to mice expressing wild-type levels of human prion protein. J Gen Virol. 2012;93:1624-9. http://dx.doi.org/10.1099/vir.0. 042507-0
12. Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, Thomson V, et al. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol. 2006;5:393-8. http://dx.doi.org/10.1016/S1474-4422(06)70413-6
13. Plinston C, Hart P, Chong A, Hunter N, Foster J, Piccardo P, et al. Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy infection following passage in sheep. J Virol. 2011;85:1174-81. http://dx.doi.org/10.1128/JVI.01578-10
14. Yokoyama T, Takeuchi A, Yamamoto M, Kitamoto T, Ironside JW, Morita M. Heparin enhances the cell-protein misfolding cyclic amplification efficiency of variant Creutzfeldt-Jakob disease. Neurosci Lett. 2011;498:119-23. http://dx.doi. org/10.1016/j.neulet.2011.04.072
15. Saá P, Castilla J, Soto C. Cyclic amplification of protein misfolding and aggregation. Methods Mol Biol. 2005;299:53-65.
16. Barria MA, Gonzalez-Romero D, Soto C. Cyclic amplification of prion protein misfolding. Methods Mol Biol. 2012;849:199-212. http://dx.doi.org/10.1007/978-1-61779-551-0_14
17. Jones M, Peden AHMW, Ironside JW. The application of in vitro cell-free conversion systems to human prion diseases. Acta Neuropathol. 2011;121:135-43. http://dx.doi.org/10.1007/s00401-010-0708-8
18. Gambetti P, Cali I, Notari S, Kong Q, Zou WQ, Surewicz WK. Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathol. 2011;121:79-90. http://dx.doi. org/10.1007/s00401-010-0761-3
19. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science. 2007;318:930-6. http://dx.doi.org/10.1126/ science.1138718
20. Marsh RF, Kincaid AE, Bessen RA, Bartz JC. Interspecies transmission of chronic wasting disease prions to squirrel monkeys (Saimiti sciureus). J Virol. 2005;79:13794-6. http://dx.doi. org/10.1128/JVI.79.21.13794-13796.2005
21. Comoy EE, Casalone C, Lescoutra-Etchegaray N, Zanusso G, Freire S, Marce D, et al. Atypical BSE (BASE) transmitted from asymptomatic aging aattle to a primate. PLoS ONE. 2008;3:e3017. http://dx.doi.org/10.1371/journal.pone.0003017
22. Race B, Meade-White KD, Miller MW, Barbian KD, Rubenstein R, LaFauci G, et al. Susceptibilities of nonhuman primates to chronic wasting disease. Emerg Infect Dis. 2009;15:1366-76. http://dx.doi. org/10.3201/eid1509.090253
23. Ono F, Tase N, Kurosawa A, Hiyaoka A, Ohyama A, Tezuka Y, et al. Atypical L-type bovine spongiform encephalopathy (L-BSE) transmission to cynomolgus macaques, a non-human primate. Jpn J Infect Dis. 2011;64:81-4.
24. Kong Q, Huang S, Zou W, Vanegas D, Wang M, Wu D, et al. Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci. 2005;25:7944-9. http:// dx.doi.org/10.1523/JNEUROSCI.2467-05.2005
25. Béringue V, Herzog L, Reine F, Le Dur A, Casalone C, Vilotte JL, et al. Transmission of atypical bovine prions to mice transgenic for human prion protein. Emerg Infect Dis. 2008;14:1898-901. http:// dx.doi.org/10.3201/eid1412.080941
26. Sandberg MK, Al-Doujaily H, Sigurdson CJ, Glatzel M, O'Malley C, Powell C, et al. Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein. J Gen Virol. 2010;91:2651-7. http://dx.doi.org/10.1099/ vir.0.024380-0
27. Tamgüney G, Giles K, Oehler A, Johnson NL, DeArmond SJ, Prusiner SB. Transmission of elk and deer prions to transgenic mice. J Virol. 2006;80:9104-14. http://dx.doi.org/10.1128/JVI.00098-06
28. Raymond GJ, Hope J, Kocisko DA, Priola SA, Raymond LD, Brossers A, et al. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature. 1997;388:285-8. http://dx.doi.org/10.1038/40876
29. Raymond GJ, Bossers A, Raymond DL, O'Rourke KI, McHolland LE, Bryant PK, et al. Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. EMBO J. 2000;19:4425-30. http://dx.doi.org/10.1093/ emboj/19.17.4425
30. Castilla J, Morales R, Saá P, Barria M, Gambetti P, Soto C. Cell-free propagation of prion strains. EMBO J. 2008;27:2557-66. http://dx.doi.org/10.1038/emboj.2008.181
31. Kurt TD, Telling GC, Zabel MD, Hoover EA. Trans-species amplification of Prp(CWD) and correlation with rigid loop 170N. Virology. 2009;387:235-43. http://dx.doi.org/10.1016/j.virol.2009.02.025
32. Green KM, Castilla J, Seward TS, Napier DL, Jewell JE, Soto C, et al. Accelerated high fidelity amplification within and across prion species barriers. PLoS Pathog. 2008;4:e1000139. http://dx.doi. org/10.1371/journal.ppat.1000139
33. Barria MA, Telling GC, Gambetti P, Mastrianni JA, Soto C. Generation of a novel form of human PrP(Sc) by inter-species transmission from cervid prions. J Biol Chem. 2011;286:7490-5. http://dx.doi. org/10.1074/jbc.M110.198465
34. Angers RC, Kang HE, Napier D, Browning S, Seward T, Mathiason C, et al. Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science. 2010;328:1154-8. http://dx.doi.org/10.1126/science.1187107
35. Perrott MR, Sigurdson CJ, Mason GL, Hoover EA. Evidence for distinct chronic wasting disease (CWD) strains in experimental CWD in ferrets. J Gen Virol. 2012;93:212-21. http://dx.doi. org/10.1099/vir.0.035006-0
36. Telling GC. Chronic wasting disease and the development of research models. In: Zou WQ, Gambetti P, editors. Prions and diseases. Volume 2. Animals, humans and the environment. New York: Springer; 2013. p. 45-56.
37. Meyerett C, Michel B, Pulford B, Spraker TR, Nichols TA, Johnson T, et al. In vitro strain adaptation of CWD prions by serial protein misfolding cyclic amplification. Virology. 2008;382:267-76. http://dx.doi.org/10.1016/j.virol.2008.09.023
38. Padilla D, Beringue V, Espinosa JC, Andreoletti O, Jaumain E, Reine F, et al. Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice. PLoS Pathog. 2011;7:e1001319. http://dx.doi.org/10.1371/journal. ppat. 1001319
39. Wilson R, King D, Hunter N, Goldmann W, Barron RM. Characterisation of an unusual transmissible spongiform encephalopathy in goat by transmission to knock-in transgenic mice. J Gen Virol. 2013;94:1922-32. http://dx.doi.org/10.1099/ vir.0.051706-0
40. Thorne L, Holder T, Ramsay A, Edwards J, Taema MM, Windl O, et al. In vitro amplification of ovine prions from scrapie-infected sheep from Great Britain reveals distinct patterns of propagation. BMC Vet Res. 2012;8:223. http://dx.doi.org/10.1186/1746-6148-8-223